TY - JOUR
T1 - Effects of Postoperative Intravitreal Injections on Outcomes of Traditional Glaucoma Surgery in Patients with Preoperative Intravitreal Injections
AU - Chang, Enchi K.
AU - Gupta, Sanchay
AU - Hall, Nathan
AU - Neeson, Cameron E.
AU - Chang, Ta C.
AU - Solá-Del Valle, David A.
N1 - Funding Information:
Obtained funding: N/A; Study was performed as part of the authors' regular employment duties. No additional funding was provided.
Publisher Copyright:
© 2021 American Academy of Ophthalmology
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Purpose: To compare outcomes of glaucoma drainage device (GDD) implantation and trabeculectomies with and without postoperative intravitreal injections (IVIs) in glaucoma patients with a history of preoperative IVIs. Design: Retrospective cohort study. Participants: A total of 133 eyes of 133 glaucoma patients who underwent GDD implantation or trabeculectomy with at least 1 IVI preoperatively between January 2005 and October 2020 at Massachusetts Eye and Ear. Methods: Chart review of glaucoma patients with traditional glaucoma surgery and at least 1 IVI before surgery. All statistical analyses were conducted with R statistical programming software. Main Outcome Measures: Intraocular pressure (IOP), medication burden, best-corrected visual acuity (BCVA), Kaplan–Meier success rates, adjusted hazard ratios (HRs), and complications. Results: Baseline demographics were similar between the groups with and without postoperative IVIs. The group with postoperative IVIs had a higher proportion of diabetic retinopathy and retinal vascular occlusions than the group without postoperative IVIs, which had more eyes with age-related macular degeneration. Intraocular pressure, medication burden, and visual acuity were similar between groups at all time points except for IOP at 6 weeks, which was lower in the group with postoperative IVIs. The group with postoperative IVIs had significantly more preoperative IVIs than the group without postoperative IVIs (6.6 vs. 3.3, P = 0.017). For success defined as IOP reduction ≥ 20% with 5 < IOP ≤ 21 mmHg, Kaplan–Meier analyses demonstrated similar success rates between groups with and without IVIs. When stratified by the number of IVIs, success rates for the group with 7 or more IVIs were significantly higher than the success rates for the group with 0–6 IVIs (P = 0.005). Each additional postoperative IVI resulted in a 7.2% decrease in the hazard of failure to achieve our stated success criteria. With regard to late complications, the group with postoperative IVIs had a higher incidence of vitreous hemorrhage (18.5% vs. 3.2%, P = 0.039) than the group without postoperative IVIs. Conclusions: A higher number of postoperative IVIs, specifically 7 or more IVIs, may be associated with improved success rates of traditional glaucoma surgery in glaucoma patients who received IVIs before surgery.
AB - Purpose: To compare outcomes of glaucoma drainage device (GDD) implantation and trabeculectomies with and without postoperative intravitreal injections (IVIs) in glaucoma patients with a history of preoperative IVIs. Design: Retrospective cohort study. Participants: A total of 133 eyes of 133 glaucoma patients who underwent GDD implantation or trabeculectomy with at least 1 IVI preoperatively between January 2005 and October 2020 at Massachusetts Eye and Ear. Methods: Chart review of glaucoma patients with traditional glaucoma surgery and at least 1 IVI before surgery. All statistical analyses were conducted with R statistical programming software. Main Outcome Measures: Intraocular pressure (IOP), medication burden, best-corrected visual acuity (BCVA), Kaplan–Meier success rates, adjusted hazard ratios (HRs), and complications. Results: Baseline demographics were similar between the groups with and without postoperative IVIs. The group with postoperative IVIs had a higher proportion of diabetic retinopathy and retinal vascular occlusions than the group without postoperative IVIs, which had more eyes with age-related macular degeneration. Intraocular pressure, medication burden, and visual acuity were similar between groups at all time points except for IOP at 6 weeks, which was lower in the group with postoperative IVIs. The group with postoperative IVIs had significantly more preoperative IVIs than the group without postoperative IVIs (6.6 vs. 3.3, P = 0.017). For success defined as IOP reduction ≥ 20% with 5 < IOP ≤ 21 mmHg, Kaplan–Meier analyses demonstrated similar success rates between groups with and without IVIs. When stratified by the number of IVIs, success rates for the group with 7 or more IVIs were significantly higher than the success rates for the group with 0–6 IVIs (P = 0.005). Each additional postoperative IVI resulted in a 7.2% decrease in the hazard of failure to achieve our stated success criteria. With regard to late complications, the group with postoperative IVIs had a higher incidence of vitreous hemorrhage (18.5% vs. 3.2%, P = 0.039) than the group without postoperative IVIs. Conclusions: A higher number of postoperative IVIs, specifically 7 or more IVIs, may be associated with improved success rates of traditional glaucoma surgery in glaucoma patients who received IVIs before surgery.
KW - Ahmed
KW - Baerveldt
KW - Glaucoma
KW - Glaucoma drainage device
KW - Glaucoma drainage implant
KW - Intravitreal injection
KW - Surgical outcomes
KW - Trabeculectomy
KW - Tube
UR - http://www.scopus.com/inward/record.url?scp=85125949270&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125949270&partnerID=8YFLogxK
U2 - 10.1016/j.ogla.2021.08.007
DO - 10.1016/j.ogla.2021.08.007
M3 - Article
C2 - 34500121
AN - SCOPUS:85125949270
VL - 5
SP - 219
EP - 228
JO - Ophthalmology. Glaucoma
JF - Ophthalmology. Glaucoma
SN - 2589-4196
IS - 2
ER -